ipledge

the ipledge program rems (risk evaluation and mitigation strategy) the ipledge program rems is a safety program to manage the?risk of isotretinoin’s teratogenicity and to minimize fetal exposure.the rems is required by the u.s. food and drug administration (fda) to ensure the benefits of isotretinoin outweigh its risks.